Build — Global Innovation Hub

Healthcare does not reward generic venture building

Healthcare demands precision, trust, and execution discipline at every stage. The Venture Studio was built to meet that standard — integrating research, product architecture, market access and strategic capital in one model.

Research before product

Every venture begins with clinical evidence and a defensible problem thesis

Architecture before growth

Products are built for real care conditions and institutional deployment.

Clinical validation before scale

Ventures earn adoption through validated pathways and measurable outcomes.

How we decide what to Build

Every venture begins with evidence. An opportunity advances only when three conditions are clear

Clinical and market relevance

A specific, documented need in real care delivery

Adoption pathway clarity

A credible route from clinical validation to institutional deployment

Platform and ecosystem fit

The venture benefits from infrastructure already built across the portfolio

Every venture at Build starts with infrastructure, not a blank page

Ventures created in the studio draws on shared healthcare technology and clinical infrastructure. Instead of rebuilding from scratch, each new company starts with production-tested components.

Agentic and intelligence stack

Agentic Platform and Engine
Visual Reasoning Engine
Clinical Decision Support Systems
Multimodal Content Generation Engine

Clinical workflow layer

AI Native EMR
Workflow Management
SOAP Note Generation
Triage and Differential Diagnosis

Data and interoperability foundation

Point of Care Screening Models
Data Ingestion Pipelines
Document Conversion and Digitization Workflows
Data Standardization through FHIR Mapping

Our ventures

CognitiveBotics

AI-powered early intervention platform for neurodiverse children

ZenSens.ai

Healthcare venture advancing through the Global Innovation Hub Venture Studio model.

Helix360

Healthcare venture developed within the Global Innovation Hub Venture Studio slate

When a venture proves clinical, operational, and commercial readiness, it moves forward to Scale, where it is expanded, accelerated, and taken into real-world systems.

Ready to Build with us?

Global Innovation Hub Venture Studio creates ventures designed to earn durable market position.

Judgement, technical depth, and disciplined execution across Venture Studio, Market Access, and Strategic Capital remain the operating standard.

Build with us

Frequently Asked Questions

What is a healthcare venture studio?

A healthcare venture studio is an organisation that builds healthcare and life sciences companies from the ground up. Unlike accelerators or incubators that support externally founded startups, a venture studio generates ideas internally, validates them through research, assembles founding teams, and provides shared technology, operational support, and capital to bring each venture to market. Global Innovation Hub operates as a venture studio focused on building companies across computational medicine, precision oncology, engineered biology, and other deep science domains.

How is Global Innovation Hub different from a healthcare accelerator or incubator?

Accelerators and incubators typically work with externally founded startups for a fixed programme duration. Global Innovation Hub builds ventures from scratch within the studio, using a research-led selection process to identify clinical needs, design products for real care environments, and validate adoption pathways before a company enters the market. Each venture also benefits from a shared technology platform that includes AI-native clinical tools, workflow infrastructure, and interoperable data systems.

What domains does the Global Innovation Hub Venture Studio focus on?

The studio builds across six priority domains where clinical need, scientific readiness, and venture economics converge: Computational Medicine, Precision Oncology, Engineered Biology, Regenerative Human Systems, Intelligent Health Machines, and Quantum Life Sciences. These sit under a broader Deep Science Platforms thesis that connects research, reusable technology, and company formation across healthcare and life sciences.

What technology infrastructure do ventures built by Global Innovation Hub use?

Every venture starts with a shared technology platform rather than building from scratch. This includes three layers: an Agentic and Intelligence Stack (covering agentic AI, visual reasoning, clinical decision support, and multimodal content generation), a Clinical Workflow Layer (AI-native EMR, workflow management, SOAP note generation, triage and differential diagnosis), and a Data and Interoperability Foundation (point-of-care screening models, data ingestion pipelines, document digitization, and FHIR-based data standardization).

How does Global Innovation Hub decide which ventures to build?

The studio uses a research-led selection process. Every opportunity must meet three standards before it advances: clinical and market relevance (a specific, documented need in real care delivery), adoption pathway clarity (a credible route from validation to institutional deployment), and platform and ecosystem fit (the venture strengthens or benefits from infrastructure already built across the portfolio). Opportunities that do not meet all three criteria do not proceed.

What companies has the Global Innovation Hub Venture Studio built?

The studio’s current portfolio includes CognitiveBotics, an AI-powered early intervention platform for neurodiverse children that translates developmental science into screening and therapy tools for clinical and educational settings; ZenSens.ai, a healthcare venture advancing through the studio model; and Helix360, a healthcare venture developed within the studio’s portfolio. Each venture is built on the studio’s shared technology platform and follows the same research-led selection and development process.

What stage are ventures at when they leave the Global Innovation Hub studio?

A venture leaves the studio only when it can operate independently. This means meeting four standards before market entry: a defensible problem thesis backed by clinical evidence, a product architecture that works under real care conditions, a validated route to institutional adoption, and the operational and capital structure required to scale on its own.

How can I partner with or invest in Global Innovation Hub?

Global Innovation Hub partners with health systems, research institutions, technology organisations, and strategic investors who share a commitment to building healthcare companies grounded in clinical evidence and institutional trust. To explore partnership or investment opportunities, visit the Global Innovation Hub website or reach out through the Partner with Global Innovation Hub page.